Arbonia Valuation
Is ARBN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ARBN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ARBN (CHF13) is trading below our estimate of fair value (CHF30.39)
Significantly Below Fair Value: ARBN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ARBN?
Other financial metrics that can be useful for relative valuation.
What is ARBN's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CHF 901.56m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.2x |
Enterprise Value/EBITDA | 17.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ARBN's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.8x | ||
SWTQ Schweiter Technologies | 0.6x | 2.7% | CHF 602.8m |
FORN Forbo Holding | 1.1x | 3.9% | CHF 1.2b |
ZEHN Zehnder Group | 0.9x | 4.9% | CHF 590.3m |
DOKA dormakaba Holding | 0.8x | 3.4% | CHF 2.2b |
ARBN Arbonia | 1.8x | 10.8% | CHF 901.6m |
Price-To-Sales vs Peers: ARBN is expensive based on its Price-To-Sales Ratio (1.8x) compared to the peer average (0.8x).
Price to Earnings Ratio vs Industry
How does ARBN's PE Ratio compare vs other companies in the European Building Industry?
Price-To-Sales vs Industry: ARBN is expensive based on its Price-To-Sales Ratio (1.8x) compared to the European Building industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is ARBN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.8x |
Fair PS Ratio | 2.3x |
Price-To-Sales vs Fair Ratio: ARBN is good value based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 13.00 | CHF 14.40 +10.8% | 5.9% | CHF 15.00 | CHF 13.20 | n/a | 3 |
Aug ’25 | CHF 12.70 | CHF 14.40 +13.4% | 5.9% | CHF 15.00 | CHF 13.20 | n/a | 3 |
Jul ’25 | CHF 12.62 | CHF 14.40 +14.1% | 5.9% | CHF 15.00 | CHF 13.20 | n/a | 3 |
Jun ’25 | CHF 12.70 | CHF 14.40 +13.4% | 5.9% | CHF 15.00 | CHF 13.20 | n/a | 3 |
May ’25 | CHF 12.14 | CHF 12.08 -0.5% | 17.3% | CHF 15.00 | CHF 10.25 | n/a | 3 |
Apr ’25 | CHF 12.06 | CHF 11.08 -8.1% | 6.5% | CHF 12.00 | CHF 10.25 | n/a | 3 |
Mar ’25 | CHF 11.82 | CHF 11.08 -6.2% | 6.5% | CHF 12.00 | CHF 10.25 | n/a | 3 |
Feb ’25 | CHF 10.14 | CHF 10.38 +2.3% | 15.7% | CHF 12.00 | CHF 8.75 | n/a | 2 |
Jan ’25 | CHF 9.63 | CHF 10.38 +7.7% | 15.7% | CHF 12.00 | CHF 8.75 | n/a | 2 |
Dec ’24 | CHF 8.30 | CHF 10.75 +29.5% | 11.6% | CHF 12.00 | CHF 9.50 | n/a | 2 |
Nov ’24 | CHF 7.85 | CHF 10.75 +36.9% | 11.6% | CHF 12.00 | CHF 9.50 | n/a | 2 |
Oct ’24 | CHF 8.39 | CHF 10.75 +28.1% | 11.6% | CHF 12.00 | CHF 9.50 | n/a | 2 |
Sep ’24 | CHF 9.05 | CHF 10.75 +18.8% | 11.6% | CHF 12.00 | CHF 9.50 | n/a | 2 |
Aug ’24 | CHF 10.10 | CHF 12.95 +28.2% | 10.6% | CHF 14.60 | CHF 11.25 | CHF 12.70 | 3 |
Jul ’24 | CHF 10.12 | CHF 13.62 +34.6% | 12.3% | CHF 15.00 | CHF 11.25 | CHF 12.62 | 3 |
Jun ’24 | CHF 10.62 | CHF 15.03 +41.6% | 2.4% | CHF 15.50 | CHF 14.60 | CHF 12.70 | 3 |
May ’24 | CHF 10.88 | CHF 15.03 +38.2% | 2.4% | CHF 15.50 | CHF 14.60 | CHF 12.14 | 3 |
Apr ’24 | CHF 10.92 | CHF 15.03 +37.7% | 2.4% | CHF 15.50 | CHF 14.60 | CHF 12.06 | 3 |
Mar ’24 | CHF 12.32 | CHF 14.90 +20.9% | 8.6% | CHF 16.50 | CHF 13.00 | CHF 11.82 | 4 |
Feb ’24 | CHF 13.06 | CHF 15.03 +15.0% | 9.1% | CHF 16.50 | CHF 13.00 | CHF 10.14 | 4 |
Jan ’24 | CHF 12.92 | CHF 15.68 +21.3% | 14.0% | CHF 19.00 | CHF 13.00 | CHF 9.63 | 4 |
Dec ’23 | CHF 14.06 | CHF 15.68 +11.5% | 14.0% | CHF 19.00 | CHF 13.00 | CHF 8.30 | 4 |
Nov ’23 | CHF 11.82 | CHF 15.93 +34.7% | 14.3% | CHF 19.00 | CHF 13.00 | CHF 7.85 | 4 |
Oct ’23 | CHF 11.32 | CHF 15.93 +40.7% | 14.3% | CHF 19.00 | CHF 13.00 | CHF 8.39 | 4 |
Sep ’23 | CHF 12.34 | CHF 16.33 +32.4% | 15.3% | CHF 19.00 | CHF 13.00 | CHF 9.05 | 3 |
Aug ’23 | CHF 13.48 | CHF 19.77 +46.6% | 22.0% | CHF 24.00 | CHF 13.80 | CHF 10.10 | 3 |
Analyst Forecast: Target price is less than 20% higher than the current share price.